Kiniksa Pharmaceuticals International (KNSA) Prepaid Assets (2017 - 2026)
Kiniksa Pharmaceuticals International's (KNSA) quarterly Prepaid Assets came in at $48.3 million in Q2 2026, up 48.85% YoY from $32.4 million in Q2 2025, and up 62.5% on a QoQ basis from $29.7 million in Q1 2026.
Kiniksa Pharmaceuticals International (KNSA) Prepaid Assets (2017 - 2026) Analysis & Trends
Kiniksa Pharmaceuticals International (KNSA) has 10 years of Prepaid Assets data on file, last reported at $48.3 million in Q2 2026.
- Quarterly Prepaid Assets rose 48.85% year-over-year to $48.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $48.3 million (up 48.85% YoY) and the FY2025 annual result came in at $42.6 million, up 112.18% from the prior year.
- Prepaid Assets grew to $48.3 million in Q2 2026, from $29.7 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $48.3 million in Q2 2026 to a low of $10.5 million in Q1 2022.
- A 5-year average of $23.5 million and a median of $22.8 million in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets slipped 11.18% — and 2024, when it soared 116.67%.
- Tracing KNSA's Prepaid Assets over 5 years: stood at $10.5 million in 2022, then surged by 66.44% to $17.5 million in 2023, then climbed by 14.52% to $20.1 million in 2024, then jumped by 112.18% to $42.6 million in 2025, then gained by 13.31% to $48.3 million in 2026.
- The last three Prepaid Assets figures came in at $48.3 million (Q2 2026), $29.7 million (Q1 2026), and $42.6 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Kiniksa Pharmaceuticals International | 6.08 Bn | 5.56 Bn | 220.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 48.29 Mn |
| Mar 31, 2026 | 29.71 Mn |
| Dec 31, 2025 | 42.61 Mn |
| Sep 30, 2025 | 30.29 Mn |
| Jun 30, 2025 | 32.44 Mn |
| Mar 31, 2025 | 25.43 Mn |
| Dec 31, 2024 | 20.08 Mn |
| Sep 30, 2024 | 33.95 Mn |
| Jun 30, 2024 | 26.95 Mn |
| Mar 31, 2024 | 13.77 Mn |
| Dec 31, 2023 | 17.54 Mn |
| Sep 30, 2023 | 26.40 Mn |
| Jun 30, 2023 | 12.44 Mn |
| Mar 31, 2023 | 13.16 Mn |
| Dec 31, 2022 | 10.54 Mn |
| Sep 30, 2022 | 15.31 Mn |
| Jun 30, 2022 | 14.01 Mn |
| Mar 31, 2022 | 10.52 Mn |
| Dec 31, 2021 | 6.59 Mn |
| Sep 30, 2021 | 8.50 Mn |